PRESS RELEASE published on 08/08/2024 at 10:00, 1 year 9 months ago SphingoTec Closes €5M Series C to Accelerate Market Development and Financial Growth with Innovative Biomarkers SphingoTec secures €5M Series C funding led by Think.Health Ventures to drive global expansion and commercialize innovative biomarkers for critical care, aiming for improved patient outcomes Funding Biomarkers SphingoTec Critical Care Series C
BRIEF published on 06/18/2024 at 10:05, 1 year 10 months ago SphingoTec Introduces PenKid at AKI & CRRT Course in Vicenza SphingoTec Biomarker AKI Kidney Function PenKid
BRIEF published on 06/18/2024 at 10:05, 1 year 10 months ago SphingoTec présente PenKid au cours AKI & CRRT à Vicence SphingoTec Biomarqueur AKI Fonction Rénale StyloKid
PRESS RELEASE published on 06/18/2024 at 10:00, 1 year 10 months ago Advancing Kidney Care With Solidified Evidence – SphingoTec Presents PenKid at AKI & CRRT Course in Vicenza SphingoTec introduces kidney function biomarker PenKid at AKI & CRRT Course. PenKid addresses AKI diagnostic gaps with real-time assessment and risk prediction capabilities SphingoTec PenKid Kidney Function Biomarker AKI & CRRT Course Biomarker Integration
BRIEF published on 03/26/2024 at 13:05, 2 years 1 month ago SphingoTec annonce des changements majeurs dans sa direction Biomarqueurs Innovations Diagnostiques Changements De Gestion SphingoTec Soin Critique
BRIEF published on 03/26/2024 at 13:05, 2 years 1 month ago SphingoTec Announces Major Management Changes Biomarkers Management Changes Diagnostic Innovations SphingoTec Critical Care
PRESS RELEASE published on 03/26/2024 at 13:00, 2 years 1 month ago SphingoTec Announces Management Changes SphingoTec announces changes in management team with new appointments. Deborah Bergmann appointed as CEO. Dr. Florian Uhle as CMO and Nicole Witzmann as CFO. Company aims to enhance critical care diagnostics Management Team Biomarkers SphingoTec Deborah Bergmann Critical Care Diagnostics
PRESS RELEASE published on 10/05/2023 at 10:00, 2 years 7 months ago New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved GFR Estimation in Steady-State and Critically Ill Patients
PRESS RELEASE published on 09/06/2023 at 10:00, 2 years 8 months ago International Experts Highlight Demand for Diagnostic Innovations as PenKid's Research and Real-World Data Fuels Quest for Improved RRT Liberation Tools
PRESS RELEASE published on 08/31/2023 at 12:30, 2 years 8 months ago Boditech Med and SphingoTec close Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid
Published on 05/11/2026 at 19:55, 2 hours 21 minutes ago Lithium South Announces Pay Out of Common Shares and Closing of Plan of Arrangement
Published on 05/11/2026 at 19:30, 2 hours 46 minutes ago Taranis Adjusts Thor Exploration Program Due to Current Political and Regulatory Conditions in British Columbia
Published on 05/11/2026 at 14:30, 7 hours 46 minutes ago Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides
Published on 05/11/2026 at 14:00, 8 hours 16 minutes ago Unusual Machines Accelerates Domestic Battery Manufacturing by Signing a Merger Agreement to Acquire Upgrade Energy
Published on 05/11/2026 at 14:00, 8 hours 16 minutes ago New Horizon Aircraft Ltd. Announces Closing of $20 Million Offering of Common Shares
Published on 05/11/2026 at 22:05, 11 minutes ago Abivax annonce les résultats de son Assemblée Générale du 11 mai 2026
Published on 05/11/2026 at 22:05, 11 minutes ago Abivax Announces Results of its May 11, 2026 Annual General Meeting
Published on 05/11/2026 at 21:16, 59 minutes ago Original-Research: Intershop Communications (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 05/11/2026 at 20:42, 1 hour 33 minutes ago Grand City Properties S.A. proposes Dividend Payment combined with Dividend Policy Update
Published on 05/11/2026 at 20:40, 1 hour 35 minutes ago EQS-Adhoc: Grand City Properties S.A. proposes Dividend Payment combined with Dividend Policy Update
Published on 05/11/2026 at 19:02, 3 hours 13 minutes ago 260511 BENETEAU Transactions sur actions propres
Published on 05/11/2026 at 18:18, 3 hours 57 minutes ago Reporting on share buyback transactions carried out between May 4 and May 5, 2026
Published on 05/11/2026 at 18:18, 3 hours 57 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 4 et 5 mai 2026
Published on 05/11/2026 at 18:14, 4 hours 1 minute ago Nombre total d'actions et droits de vote - avril 2026
Published on 05/11/2026 at 18:14, 4 hours 1 minute ago Number of shares and voting rights - April 2026 (In French only)